Armando Lira Pineda - Publications, H-index & Citations

Back

Armando Lira Pineda

Institut Universitaire de France

15H-index

33Paper Count

4.2KCitation Count

Published Papers 17

Publication Date

Icosapent Ethyl Reduces CVD Risk in Cardiovascular-Kidney-Metabolic Syndrome: REDUCE-IT CKM

American Journal of Preventive Cardiology

IF5.9

2025-12-19

OAAI

Michael Miller; Deepak L. Bhatt; Eliot A. Brinton; Terry A. Jacobson; Ph. Gabriel Steg; Steven B. Ketchum; Armando Lira Pineda; Jean-Claude Tardif; Christie M. Ballantyne

Save

Benefit of icosapent ethyl across types and sizes of myocardial infarction in REDUCE-IT

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2025-11-01

OAAI

Gurevitz, Chen; Bhatt, Deepak L.; Giugliano, Robert P.; Steg, Ph Gabriel; Miller, Michael; Brinton, Eliot A.; Jacobson, Terry A.; Ketchum, Steven B.; Pineda, Armando Lira; Doyle, Ralph T.; Giugliano, Gabriella; Mason, R. Preston; Tardif, Jean-Claude; Martens, Fabrice M. A. C.; Ballantyne, Christie M.; Budoff, Matthew J.; Gibson, C. Michael

Save

Substantial cardiovascular risk reduction with icosapent ethyl in patients with prior cardiovascular events regardless of coronary artery disease history: REDUCE-IT CAD

CIRCULATION

IF38.6

2024-11-12

PREAI

Aggarwal, Rahul; Bhatt, Deepak; Ballantyne, Christie; Miller, Michael; Brinton, Eliot; Jacobson, Terry; Ketchum, Steven; Pineda, Armando Lira; Doyle, Ralph; Tardif, Jean-Claude; Steg, Philippe

Save

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

EUROPEAN HEART JOURNAL

IF35.6

2024-01-22

OAAI

Sayah, Neila; Bhatt, Deepak L.; Miller, Michael; Brinton, Eliot A.; Jacobson, Terry A.; Ketchum, Steven B.; Jiao, Lixia; Pineda, Armando Lira; Doyle, Ralph T.; Tardif, Jean Claude; Ballantyne, Christie M.; Steg, Ph Gabriel

Save

Effectiveness of Icosapent Ethyl on First and Total Cardiovascular Events in the Metabolic Syndrome: REDUCE-IT MetSyn

CIRCULATION

IF38.6

2023-11-07

PREAI

Miller, Michael; Bhatt, Deepak; Brinton, Eliot A.; Jacobson, Terry A.; Steg, Philippe G.; Pineda, Armando L.; Ketchum, Steven; Doyle, Ralph; Tardif, Jean-Claude; Ballantyne, Christie M.

Save

Canmachine learning bring cardiovascular risk assessment to the next level? Amethodological study using FOURIER trial data

EUROPEAN HEART JOURNAL - DIGITAL HEALTH

IF4.4

2021-11-15

OAAI

Rousset, Adrien; Dellamonica, David; Menuet, Romuald; Pineda, Armando Lira; Sabatine, Marc S.; Giugliano, Robert P.; Trichelair, Paul; Zaslavskiy, Mikhail; Ricci, Lea

Save

Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial -

CIRCULATION JOURNAL

IF3.7

2021-10-25

OAAI

Keech, Anthony C.; Oyama, Kazuma; Sever, Peter S.; Tang, Minao; Murphy, Sabina A.; Hirayama, Atsushi; Lu, Chen; Tay, Leslie; Deedwania, Prakash C.; Siu, Chung-Wah; Pineda, Armando Lira; Choi, Donghoon; Charng, Min-Ji; Amerena, John; Ahmad, Wan Azman Wan; Chopra, Vijay K.; Pedersen, Terje R.; Giugliano, Robert P.; Sabatine, Marc S.

Save

Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy

CIRCULATION

IF38.6

2021-07-20

OAAI

Marston, Nicholas A.; Oyama, Kazuma; Jarolim, Petr; Tang, Minao; Sever, Peter S.; Keech, Anthony C.; Lira Pineda, Armando; Wang, Huei; Giugliano, Robert P.; Sabatine, Marc S.; Morrow, David A.

Save

Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy Secondary Analysis From the FOURIER Randomized Clinical Trial

JAMA CARDIOLOGY

IF14.1

2021-02-01

OAAI

Deedwania, Prakash; Murphy, Sabina A.; Scheen, Andre; Badariene, Jolita; Pineda, Armando Lira; Honarpour, Narimon; Keech, Anthony C.; Sever, Peter S.; Pedersen, Terje R.; Sabatine, Marc S.; Giugliano, Robert P.

Save

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

STROKE

IF8.9

2020-05-01

118

OAAI

Giugliano, Robert P.; Pedersen, Terje R.; Saver, Jeffrey L.; Sever, Peter S.; Keech, Anthony C.; Bohula, Erin A.; Murphy, Sabina A.; Wasserman, Scott M.; Honarpour, Narimon; Wang, Huei; Lira Pineda, Armando; Sabatine, Marc S.

Save

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score Results From the FOURIER Trial

CIRCULATION

IF38.6

2020-02-25

136

OAAI

Marston, Nicholas A.; Kamanu, Frederick K.; Nordio, Francesco; Gurmu, Yared; Roselli, Carolina; Sever, Peter S.; Pedersen, Terje R.; Keech, Anthony C.; Wang, Huei; Pineda, Armando Lira; Giugliano, Robert P.; Lubitz, Steven A.; Ellinor, Patrick T.; Sabatine, Marc S.; Ruff, Christian T.

Save

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial

CIRCULATION

IF38.6

2019-03-19

561

OAAI

O'Donoghue, Michelle L.; Fazio, Sergio; Giugliano, Robert P.; Stroes, Erik S. G.; Kanevsky, Estella; Gouni-Berthold, Ioanna; Im, KyungAh; Pineda, Armando Lira; Wasserman, Scott M.; Ceska, Richard; Ezhov, Marat V.; Jukema, J. Wouter; Jensen, Henrik K.; Tokgozoglu, S. Lale; Mach, Francois; Huber, Kurt; Sever, Peter S.; Keech, Anthony C.; Pedersen, Terje R.; Sabatine, Marc S.

Save

LIPOPROTEIN(A), PCSK9 INHIBITION AND CARDIOVASCULAR RISK: INSIGHTS FROM THE FOURIER TRIAL

ATHEROSCLEROSIS

IF5.7

2018-08-01

PREAI

O'Donoghue, M.; Giugliano, R.; Keech, A.; Kanevsky, E.; Im, K.; Lira, A.; Pineda, A. Lira; Somaratne, R.; Sever, P.; Pederson, T.; Sabatine, M.

Save

Inflammatory and Cholesterol Risk in the FOURIER Trial

CIRCULATION

IF38.6

2018-07-10

198

OAAI

Bohula, Erin A.; Giugliano, Robert P.; Leiter, Lawrence A.; Verma, Subodh; Park, Jeong-Gun; Sever, Peter S.; Pineda, Armando Lira; Honarpour, Narimon; Wang, Huei; Murphy, Sabina A.; Keech, Anthony; Pedersen, Terje R.; Sabatine, Marc S.

Save

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

CIRCULATION

IF38.6

2018-01-23

601

OAAI

Bonaca, Marc P.; Nault, Patrice; Giugliano, Robert P.; Keech, Anthony C.; Pineda, Armando Lira; Kanevsky, Estella; Kuder, Julia; Murphy, Sabina A.; Jukema, J. Wouter; Lewis, Basil S.; Tokgozoglu, Lale; Somaratne, Ransi; Sever, Peter S.; Pedersen, Terje R.; Sabatine, Marc S.

Save

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial

JAMA CARDIOLOGY

IF14.1

2017-12-01

OAAI

Giugliano, Robert P.; Keech, Anthony; Murphy, Sabina A.; Huber, Kurt; Tokgozoglu, S. Lale; Lewis, Basil S.; Ferreira, Jorge; Pineda, Armando Lira; Somaratne, Ransi; Sever, Peter S.; Pedersen, Terje R.; Sabatine, Marc S.

Save

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

LANCET

IF88.5

2017-10-01

484

PREAI

Giugliano, Robert P.; Pedersen, Terje R.; Park, Jeong-Gun; De Ferrari, Gaetano M.; Gaciong, Zbigniew A.; Ceska, Richard; Toth, Kalman; Gouni-Berthold, Ioanna; Lopez-Miranda, Jose; Schiele, Francois; Mach, Francois; Ott, Brian R.; Kanevsky, Estelle; Pineda, Armando Lira; Somaratne, Ransi; Wasserman, Scott M.; Keech, Anthony C.; Sever, Peter S.; Sabatine, Marc S.

Save

Research Directions